73
Participants
Start Date
October 4, 2016
Primary Completion Date
June 10, 2024
Study Completion Date
June 10, 2024
Midazolam Hydrochloride
Short-acting sedative. Benzodiazepine. Gamma-aminobutyric acid (GABA) inhibitor
Fentanyl
Synthetic opioid drug used as an analgesic.
Ketamine
General Anesthetic. N-methyl-D-aspartate (NMDA) receptor agonist
Propofol injection
General Anesthetic. GABA receptor modulator and calcium channel blocker
Nitrous oxide
Modulates a wide range of ligand-gated ion channels and inhibits NMDA receptor-mediated currents
NYCHHC - Jacobi Medical Center and North Central Bronx Hospital, The Bronx
Albert Einstein College of Medicine
OTHER